期刊论文详细信息
BMC Nephrology
Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease
Jean-Jacques Boffa4  Pierre Ronco4  Virginie Jousselin3  Valérie Chigot2  Jean-Manuel Faintuch2  Patrice Callard1  Pierre Patrick Lévy5  Naïke Bigé3 
[1] Department of Pathology, AP-HP, Hôpital Tenon, Paris, F-75020, France;Department of Radiology, AP-HP, Hôpital Tenon, Paris, F-75020, France;Department of Nephrology, AP-HP, Hôpital Tenon, 4 rue de la Chine, Paris, F-75020, France;Université Pierre et Marie Curie-Paris 6, UMR S 702 , Paris, France;Université Pierre et Marie Curie-Paris 6, UMR-S 707, Paris, F-75012, France
关键词: Renal doppler;    Fibrosis;    Arteriosclerosis;    Chronic kidney disease;   
Others  :  1083072
DOI  :  10.1186/1471-2369-13-139
 received in 2012-04-25, accepted in 2012-09-25,  发布年份 2012
PDF
【 摘 要 】

Background

Chronic kidney disease (CKD) is a growing public health problem and end stage renal disease (ESRD) represents a large human and economic burden. It is important to identify patients at high risk of ESRD. In order to determine whether renal Doppler resistive index (RI) may discriminate those patients, we analyzed whether RI was associated with identified prognosis factors of CKD, in particular histological findings, and with renal outcome.

Methods

RI was measured in the 48 hours before renal biopsy in 58 CKD patients. Clinical and biological data were collected prospectively at inclusion. Arteriosclerosis, interstitial fibrosis and glomerulosclerosis were quantitatively assessed on renal biopsy in a blinded fashion. MDRD eGFR at 18 months was collected for 35 (60%) patients. Renal function decline was defined as a decrease in eGFR from baseline of at least 5 mL/min/ 1.73 m2/year or need for chronic renal replacement therapy. Pearson’s correlation, Mann–Whitney and Chi-square tests were used for analysis of quantitative and qualitative variables respectively. Kaplan Meier analysis was realized to determine renal survival according to RI value using the log-rank test. Multiple logistic regression was performed including variables with p < 0.20 in univariate analysis.

Results

Most patients had glomerulonephritis (82%). Median age was 46 years [21–87], eGFR 59 mL/min/ 1.73m2 [5–130], percentage of interstitial fibrosis 10% [0–90], glomerulosclerosis 13% [0–96] and RI 0.63 [0.31-1.00]. RI increased with age (r = 0.435, p = 0.0063), pulse pressure (r = 0.303, p = 0.022), renal atrophy (r = −0.275, p = 0.038) and renal dysfunction (r = −0.402, p = 0.0018). Patients with arterial intima/media ratio ≥ 1 (p = 0.032), interstitial fibrosis > 20% (p = 0.014) and renal function decline (p = 0.0023) had higher RI. Patients with baseline RI ≥ 0.65 had a poorer renal outcome than those with baseline RI < 0.65 (p = 0.0005). In multiple logistic regression, RI≥0.65 was associated with accelerated renal function decline independently of baseline eGFR and proteinuria/creatininuria ratio (OR=13.04 [1.984-85.727], p = 0.0075). Sensitivity, specificity, predictive positive and predictive negative values of RI ≥ 0.65 for renal function decline at 18 months were respectively 77%, 86%, 71% and 82%.

Conclusions

Our results suggest that RI ≥ 0.65 is associated with severe interstitial fibrosis and arteriosclerosis and renal function decline. Thus, RI may contribute to identify patients at high risk of ESRD who may benefit from nephroprotective treatments.

【 授权许可】

   
2012 Bigé et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20141224194141104.pdf 928KB PDF download
Figure 4. 14KB Image download
Figure 3. 89KB Image download
Figure 2. 55KB Image download
Figure 1. 59KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]Meguid El Nahas A, Bello AK: Chronic kidney disease: the global challenge. Lancet 2005, 365(9456):331-340.
  • [2]Eriksen BO, Ingebretsen OC: The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006, 69(2):375-382.
  • [3]Clark LE, Khan I: Outcomes in CKD: what we know and what we need to know. Nephron 2010, 114(2):c95-c102.
  • [4]Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992, 20(1):1-17.
  • [5]Crutchley TA, Pearce JD, Craven TE, Stafford JM, Edwards MS, Hansen KJ: Clinical utility of the resistive index in atherosclerotic renovascular disease. J Vasc Surg 2009, 49(1):148-155. 155 e141-143; discussion 155
  • [6]Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H: Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001, 344(6):410-417.
  • [7]Rodrigo E, Lopez-Rasines G, Ruiz JC, Lastra P, Gomez-Dermitt V, Gomez-Alamillo C, Gonzalez-Cotorruelo J, Calabia A, Arias M: Determinants of resistive index shortly after transplantation: independent relationship with delayed graft function. Nephron 2010, 114(3):c178-c186.
  • [8]Radermacher J, Mengel M, Ellis S, Stuht S, Hiss M, Schwarz A, Eisenberger U, Burg M, Luft FC, Gwinner W, et al.: The renal arterial resistance index and renal allograft survival. N Engl J Med 2003, 349(2):115-124.
  • [9]Ikee R, Kobayashi S, Hemmi N, Imakiire T, Kikuchi Y, Moriya H, Suzuki S, Miura S: Correlation between the resistive index by Doppler ultrasound and kidney function and histology. Am J Kidney Dis 2005, 46(4):603-609.
  • [10]Mostbeck GH, Kain R, Mallek R, Derfler K, Walter R, Havelec L, Tscholakoff D: Duplex Doppler sonography in renal parenchymal disease. Histopathologic correlation. J Ultrasound Med 1991, 10(4):189-194.
  • [11]Splendiani G, Parolini C, Fortunato L, Sturniolo A, Costanzi S: Resistive index in chronic nephropathies: predictive value of renal outcome. Clin Nephrol 2002, 57(1):45-50.
  • [12]Sugiura T, Nakamori A, Wada A, Fukuhara Y: Evaluation of tubulointerstitial injury by Doppler ultrasonography in glomerular diseases. Clin Nephrol 2004, 61(2):119-126.
  • [13]Sugiura T, Wada A: Resistive index predicts renal prognosis in chronic kidney disease. Nephrol Dial Transplant 2009, 24(9):2780-2785.
  • [14]Parolini C, Noce A, Staffolani E, Giarrizzo GF, Costanzi S, Splendiani G: Renal resistive index and long-term outcome in chronic nephropathies. Radiology 2009, 252(3):888-896.
  • [15]Petersen LJ, Petersen JR, Talleruphuus U, Ladefoged SD, Mehlsen J, Jensen HA: The pulsatility index and the resistive index in renal arteries. Associations with long-term progression in chronic renal failure. Nephrol Dial Transplant 1997, 12(7):1376-1380.
  • [16]Radermacher J, Ellis S, Haller H: Renal resistance index and progression of renal disease. Hypertension 2002, 39(2 Pt 2):699-703.
  • [17]Okura T, Kurata M, Irita J, Enomoto D, Jotoku M, Nagao T, Koresawa M, Kojima S, Hamano Y, Mashiba S, et al.: Renal resistance index is a marker of future renal dysfunction in patients with essential hypertension. J Nephrol 2010, 23(2):175-180.
  • [18]National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(2 Suppl 1):S1-S266.
  • [19]Conway B, Webster A, Ramsay G, Morgan N, Neary J, Whitworth C, Harty J: Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Transplant 2009, 24(6):1930-1937.
  • [20]Eriksen BO, Ingebretsen OC: In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. Kidney Int 2007, 72(10):1242-1248.
  • [21]Halbesma N, Kuiken DS, Brantsma AH, Bakker SJ, Wetzels JF, De Zeeuw D, De Jong PE, Gansevoort RT: Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol 2006, 17(9):2582-2590.
  • [22]Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE: Predictors of the progression of renal disease in the modification of diet in renal disease study. Kidney Int 1997, 51(6):1908-1919.
  • [23]John R, Webb M, Young A, Stevens PE: Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 2004, 43(5):825-835.
  • [24]Farris AB, Adams CD, Brousaides N, Della Pelle PA, Collins AB, Moradi E, Smith RN, Grimm PC, Colvin RB: Morphometric and visual evaluation of fibrosis in renal biopsies. J Am Soc Nephrol 2011, 22(1):176-186.
  • [25]Platt JF, Ellis JH, Rubin JM, DiPietro MA, Sedman AB: Intrarenal arterial Doppler sonography in patients with nonobstructive renal disease: correlation of resistive index with biopsy findings. Ajr 1990, 154(6):1223-1227.
  • [26]Heine GH, Gerhart MK, Ulrich C, Kohler H, Girndt M: Do ultrasound renal resistance indices reflect systemic rather than renal vascular damage in chronic kidney disease? Nephrol Dial Transplant 2006, 22(1):163-170.
  • [27]Keogan MT, Kliewer MA, Hertzberg BS, DeLong DM, Tupler RH, Carroll BA: Renal resistive indexes: variability in Doppler US measurement in a healthy population. Radiology 1996, 199(1):165-169.
  • [28]Lin ZY, Wang LY, Yu ML, Dai CY, Chen SC, Chuang WL, Hsieh MY, Tsai JF, Chang WY: Influence of age on intrarenal resistive index measurement in normal subjects. Abdom Imaging 2003, 28(2):230-232.
  • [29]Rivolta R, Cardinale L, Lovaria A, Di Palo FQ: Variability of renal echo-Doppler measurements in healthy adults. J Nephrol 2000, 13(2):110-115.
  • [30]Florczak E, Januszewicz M, Januszewicz A, Prejbisz A, Kaczmarska M, Michalowska I, Kabat M, Rywik T, Rynkun D, Zielinski T, et al.: Relationship between renal resistive index and early target organ damage in patients with never-treated essential hypertension. Blood Press 2009, 18(1–2):55-61.
  • [31]Ohta Y, Fujii K, Arima H, Matsumura K, Tsuchihashi T, Tokumoto M, Tsuruya K, Kanai H, Iwase M, Hirakata H, et al.: Increased renal resistive index in atherosclerosis and diabetic nephropathy assessed by Doppler sonography. J Hypertens 2005, 23(10):1905-1911.
  • [32]Okura T, Watanabe S, Miyoshi K, Fukuoka T, Higaki J: Intrarenal and carotid hemodynamics in patients with essential hypertension. Am J Hypertens 2004, 17(3):240-244.
  • [33]Ozelsancak R, Torun D, Koc Z, Sezer S, Ozdemir FN, Niron EA: Relationship between renal resistive index and inflammation in untreated hypertensive patients. Int Heart J 2009, 50(6):753-761.
  • [34]Raff U, Schmidt BM, Schwab J, Schwarz TK, Achenbach S, Bar I, Schmieder RE: Renal resistive index in addition to low-grade albuminuria complements screening for target organ damage in therapy-resistant hypertension. J Hypertens 2010, 28(3):608-614.
  • [35]Heine GH, Gerhart MK, Ulrich C, Kohler H, Girndt M: Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients. Kidney Int 2005, 68(2):878-885.
  • [36]Pontremoli R, Viazzi F, Martinoli C, Ravera M, Nicolella C, Berruti V, Leoncini G, Ruello N, Zagami P, Bezante GP, et al.: Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. Nephrol Dial Transplant 1999, 14(2):360-365.
  • [37]Shimizu Y, Itoh T, Hougaku H, Nagai Y, Hashimoto H, Sakaguchi M, Handa N, Kitagawa K, Matsumoto M, Hori M: Clinical usefulness of duplex ultrasonography for the assessment of renal arteriosclerosis in essential hypertensive patients. Hypertens Res 2001, 24(1):13-17.
  • [38]Buscemi S, Verga S, Batsis JA, Cottone S, Mattina A, Re A, Arnone M, Citarda S, Cerasola G: Intra-renal hemodynamics and carotid intima-media thickness in the metabolic syndrome. Diabetes Res Clin Pract 2009, 86(3):177-185.
  • [39]Pearce JD, Craven TE, Edwards MS, Corriere MA, Crutchley TA, Fleming SH, Hansen KJ: Associations between renal duplex parameters and adverse cardiovascular events in the elderly: a prospective cohort study. Am J Kidney Dis 2010, 55(2):281-290.
  • [40]Galesic K, Sabljar-Matovinovic M, Tomic M, Brkljacic B: Renal vascular resistance in glomerular diseases–correlation of resistance index with biopsy findings. Coll Antropol 2004, 28(2):667-674.
  • [41]Kim SH, Kim WH, Choi BI, Kim CW: Duplex Doppler US in patients with medical renal disease: resistive index vs serum creatinine level. Clin Radiol 1992, 45(2):85-87.
  • [42]Petersen LJ, Petersen JR, Ladefoged SD, Mehlsen J, Jensen HA: The pulsatility index and the resistive index in renal arteries in patients with hypertension and chronic renal failure. Nephrol Dial Transplant 1995, 10(11):2060-2064.
  • [43]Yura T, Yuasa S, Sumikura T, Takahashi N, Aono M, Kunimune Y, Fujioka H, Miki S, Takamitsu Y, Matsuo H: Doppler sonographic measurement of phasic renal artery blood flow velocity in patients with chronic glomerulonephritis. J Ultrasound Med 1993, 12(4):215-219.
  • [44]Sari A, Dinc H, Zibandeh A, Telatar M, Gumele HR: Value of resistive index in patients with clinical diabetic nephropathy. Invest Radiol 1999, 34(11):718-721.
  • [45]Saracino A, Santarsia G, Latorraca A, Gaudiano V: Early assessment of renal resistance index after kidney transplant can help predict long-term renal function. Nephrol Dial Transplant 2006, 21(10):2916-2920.
  文献评价指标  
  下载次数:10次 浏览次数:1次